Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Epidemiol Infect ; 147: e219, 2019 01.
Article in English | MEDLINE | ID: mdl-31364561

ABSTRACT

In 2013, the national surveillance case definition for West Nile virus (WNV) disease was revised to remove fever as a criterion for neuroinvasive disease and require at most subjective fever for non-neuroinvasive disease. The aims of this project were to determine how often afebrile WNV disease occurs and assess differences among patients with and without fever. We included cases with laboratory evidence of WNV disease reported from four states in 2014. We compared demographics, clinical symptoms and laboratory evidence for patients with and without fever and stratified the analysis by neuroinvasive and non-neuroinvasive presentations. Among 956 included patients, 39 (4%) had no fever; this proportion was similar among patients with and without neuroinvasive disease symptoms. For neuroinvasive and non-neuroinvasive patients, there were no differences in age, sex, or laboratory evidence between febrile and afebrile patients, but hospitalisations were more common among patients with fever (P < 0.01). The only significant difference in symptoms was for ataxia, which was more common in neuroinvasive patients without fever (P = 0.04). Only 5% of non-neuroinvasive patients did not meet the WNV case definition due to lack of fever. The evidence presented here supports the changes made to the national case definition in 2013.


Subject(s)
Asymptomatic Diseases/epidemiology , Fever/epidemiology , West Nile Fever/diagnosis , West Nile Fever/epidemiology , West Nile virus/isolation & purification , California/epidemiology , Clinical Laboratory Techniques/methods , Female , Fever/diagnosis , Humans , Incidence , Louisiana/epidemiology , Male , Massachusetts/epidemiology , Minnesota/epidemiology , Population Surveillance , Retrospective Studies , Risk Assessment , Severity of Illness Index
2.
J Mol Microbiol Biotechnol ; 3(1): 103-12, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11200222

ABSTRACT

To evaluate matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF MS) as a tool for rapid identification of common clinical bacterial isolates, we analyzed 25 carefully selected isolates of pathogenic Escherichia coli (E. coli) and additional Enterobacteriaceae members. Organisms were prepared according to clinical microbiological protocols and analyzed with minimal additional processing. Spectra were reproducible from preparation to preparation and comprised 40-100 peaks primarily representing intracellular proteins with masses up to 25 kDa. Spectra of 14 genetically diverse bacteremic isolates of E. coli were compared with isolates representing other genera within the Enterobacteriaceae family. Using a new spectrum comparison algorithm, E. coli isolates were closely related to each other and were readily distinguishable from other Enterobacteriaceae, including Salmonella and Shigella. Presently, the methodology permits the analysis of 40 unknown isolates per hour per instrument. These results suggest that MALDI-ToF MS offers a rapid and reliable approach for performing phyloproteomics i.e., identification of unknown bacterial isolates based on similarities within protein biomarker databases.


Subject(s)
Bacterial Proteins/analysis , Enterobacteriaceae/chemistry , Escherichia coli/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Enterobacteriaceae/classification , Enterobacteriaceae/growth & development , Enterobacteriaceae/isolation & purification , Escherichia coli/classification , Escherichia coli/growth & development , Escherichia coli/isolation & purification , Phylogeny , Sensitivity and Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/instrumentation
3.
Int J Syst Bacteriol ; 48 Pt 3: 1015-24, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9734058

ABSTRACT

Several yeast species/isolates belonging to the genus Saccharomyces were examined for the organization of their mtDNAs and ability to generate petite mutants. A general characteristic for all of the mtDNAs tested was that they were very A+T-rich. However, restriction patterns and inducibility of petite mutations revealed a great diversity in the organization and genetic behaviour of mtDNAs. One group of yeasts, Saccharomyces sensu stricto, contains mtDNA ranging in size from 64 to 85 kb. mtDNAs form these yeasts contain a high number of restriction sites that are recognized by the enzymes Haelll and Mspl, which cut specifically in G+C clusters. There are three to nine ori/rep sequences per genome. These yeasts spontaneously generate respiration deficient mutants. Ethidium bromide (Et-Br), at low concentrations, induces a majority of cells to give rise to petites. A second group of yeasts, Saccharomyces sensu lato, contains smaller mtDNAs, ranging in size from 23 to 48 kb, and probably only a few intergenic G+C clusters and no ori/rep sequences. These yeasts also generate petite clones spontaneously. but Et-Br, even when present at high concentrations, does not substantially increase the frequency of petites. In most petite clones from these yeasts only a small fragment of the wild-type molecule is retained and apparently multiplied. A third group, represented by Saccharomyces kluyveri, does not give rise to petite mutants either spontaneously or after induction.


Subject(s)
DNA, Fungal/chemistry , DNA, Mitochondrial/chemistry , Saccharomyces/genetics , Base Composition , Restriction Mapping
4.
J Clin Microbiol ; 36(4): 1109-12, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9542948

ABSTRACT

The performance of a second-generation rapid agglutination kit, Slidex Staph Plus (SSP; bioMérieux), was compared to those of the Slidex Staph (SS; bioMérieux), Staphaurex (SRX; Murex Diagnostics), and BBL Staphyloslide (BBL; Becton Dickinson) kits by using 508 clinical isolates composed of 150 methicillin-sensitive Staphylococcus aureus (MSSA) organisms, 154 methicillin-resistant S. aureus (MRSA) organisms, and 204 non-S. aureus Staphylococcus spp. Of the 508 isolates tested, 75% were fresh clinical isolates, with the remainder taken from five different freezer collections. All four agglutination tests had comparable sensitivities for MSSA and MRSA. However, the SS kit was significantly less specific (93.1%) than the three other tests (P > 0.05, McNemar test). These results demonstrate that the new rapid latex agglutination kit, SSP, was more specific for the identification of S. aureus than the previous version and performed comparably to the SRX and BBL kits.


Subject(s)
Methicillin Resistance , Staphylococcus aureus/isolation & purification , DNA, Bacterial/analysis , Latex Fixation Tests , Nucleic Acid Hybridization , Reagent Kits, Diagnostic , Sensitivity and Specificity , Staphylococcus aureus/drug effects
5.
J Leukoc Biol ; 56(3): 310-7, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7916029

ABSTRACT

To investigate mechanisms that facilitate transendothelial migration of HIV-infected leukocytes and their interactions with neural tissues early in the disease, we studied peripheral blood from Centers for Disease Control class A patients. Patients' monocytes displayed increased quantities of the adhesion molecules CD11a, CD11b, and very late antigen 4 (VLA-4). Expression of these correlated directly with the numbers of monocytes that migrated through confluent endothelium. These ligands also mediated leukocyte interactions with cultured human neural cell lines. Although patients' cells bound in greater numbers, there was no evidence of target cell injury. To evaluate the direct effect of HIV-1 on monocyte neuroadhesion, we compared infected with uninfected monocytoid (U-937,THP-1) and T lymphoblastoid (MT-4) cell lines. HIV infection increased the neuroadhesiveness of monocytoid lines only. By using lines with more than 95% HIV-infected cells, we demonstrated that HIV-1 gp120 participates with lymphocyte function-associated antigen 1 and VLA-4 to mediate monocyte-neural cell interactions.


Subject(s)
Acquired Immunodeficiency Syndrome/physiopathology , HIV-1/isolation & purification , Monocytes , Neurons/pathology , Acquired Immunodeficiency Syndrome/pathology , Antibodies, Monoclonal/pharmacology , Antigens, CD/analysis , Antigens, CD/physiology , CD11 Antigens , Cell Adhesion/physiology , Cell Communication/physiology , Cell Line , Cell Movement/physiology , Endothelium, Vascular/cytology , Endothelium, Vascular/physiology , Flow Cytometry , HIV Envelope Protein gp120/analysis , HIV Envelope Protein gp120/physiology , Humans , Leukocytes/pathology , Leukocytes/physiology , Monocytes/microbiology , Monocytes/pathology , Monocytes/physiology , Neurons/chemistry , Neurons/physiology , Phagocytes/pathology , Phagocytes/physiology , Phenotype , Reactive Oxygen Species/metabolism , Receptors, Very Late Antigen/analysis , Receptors, Very Late Antigen/physiology
6.
J Virol ; 67(2): 1075-9, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8093488

ABSTRACT

Measles virus (MV) infection of U937 cell or peripheral blood leukocyte cultures was shown to induce changes in the expression of leukocyte function antigen 1 (LFA-1) and cause marked aggregation of these cells. Addition of selected monoclonal antibodies specific for LFA-1 epitopes that did not neutralize MV in standard neutralization assays were found to block both virus-induced leukocyte aggregation and virus dissemination. These data suggest that MV modulation of LFA-1 expression on leukocytes may be an important step in MV pathogenesis.


Subject(s)
Antigens, CD/biosynthesis , Leukocytes, Mononuclear/microbiology , Lymphocyte Function-Associated Antigen-1/biosynthesis , Measles virus/physiology , Measles/etiology , Antibodies, Monoclonal/pharmacology , CD18 Antigens , Cell Aggregation/drug effects , Culture Media/pharmacology , Flow Cytometry , Gene Expression Regulation , Humans , Integrins/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...